139 related articles for article (PubMed ID: 38510682)
1. Clinical significance of
Ogawa M; Moriyama M; Nakamura H; Shibata T; Kuroda K; Sugitani M
J Clin Biochem Nutr; 2024 Mar; 74(2):169-178. PubMed ID: 38510682
[TBL] [Abstract][Full Text] [Related]
2. The proliferation of atypical hepatocytes and CDT1 expression in noncancerous tissue are associated with the postoperative recurrence of hepatocellular carcinoma.
Moriyama M; Kanda T; Midorikawa Y; Matsumura H; Masuzaki R; Nakamura H; Ogawa M; Matsuoka S; Shibata T; Yamazaki M; Kuroda K; Nakayama H; Higaki T; Kanemaru K; Miki T; Sugitani M; Takayama T
Sci Rep; 2022 Nov; 12(1):20508. PubMed ID: 36443564
[TBL] [Abstract][Full Text] [Related]
3. The significance of CDT1 expression in non-cancerous and cancerous liver in cases with hepatocellular carcinoma.
Ogawa M; Moriyama M; Midorikawa Y; Nakamura H; Shibata T; Kuroda K; Nakayama H; Kanemaru K; Miki T; Sugitani M; Takayama T
J Clin Biochem Nutr; 2023 Nov; 73(3):234-248. PubMed ID: 37970553
[TBL] [Abstract][Full Text] [Related]
4. Involvement of proliferation of atypical hepatocytes and CDT 1 in the liver cancer of rats administered the diethylnitrosamine.
Ogawa M; Masuzaki R; Kanda T; Matsumura H; Nakamura H; Yamazaki M; Shibata T; Kogure H; Moriyama M
J Clin Biochem Nutr; 2023 Sep; 73(2):138-144. PubMed ID: 37700853
[TBL] [Abstract][Full Text] [Related]
5. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
Front Oncol; 2021; 11():721644. PubMed ID: 34631549
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CDT1 Is a Predictor of Poor Survival in Patients with Hepatocellular Carcinoma.
Karavias D; Maroulis I; Papadaki H; Gogos C; Kakkos S; Karavias D; Bravou V
J Gastrointest Surg; 2016 Mar; 20(3):568-79. PubMed ID: 26408331
[TBL] [Abstract][Full Text] [Related]
7. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
Tsai PC; Kuo HT; Hung CH; Tseng KC; Lai HC; Peng CY; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Kao JH; Liu CJ; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Tai CM; Lin CW; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Yeh ML; Huang CF; Hsieh MH; Huang JF; Dai CY; Chung WL; Chen CY; Yu ML;
J Hepatol; 2023 Feb; 78(2):281-292. PubMed ID: 36208843
[TBL] [Abstract][Full Text] [Related]
8. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
[TBL] [Abstract][Full Text] [Related]
10. The Bcl-2 and TGF-beta1 levels in patients with chronic hepatitis C, liver cirrhosis and hepatocellular carcinoma.
Ali MA; Koura BA; el-Mashad N; Zaghloul MH
Egypt J Immunol; 2004; 11(1):83-90. PubMed ID: 15724390
[TBL] [Abstract][Full Text] [Related]
11. Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma.
El-Bassiouni NE; Nosseir MM; Madkour ME; Zoheiry MM; Bekheit IW; Ibrahim RA; Ibrahim IM; El Bassiouny AE
Mol Biol Rep; 2012 Jun; 39(6):6843-50. PubMed ID: 22318548
[TBL] [Abstract][Full Text] [Related]
12. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.
Wong DK; Cheng SCY; Mak LL; To EW; Lo RC; Cheung TT; Seto WK; Fung J; Man K; Lai CL; Yuen MF
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):449-456. PubMed ID: 31252193
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of TNF a mRNA and VEGF mRNA expression in patients with chronic hepatitis C genotype-4, with and without cirrhosis and hepatocellular carcinoma to predict disease outcome.
Kishta SA; Abd-Alhade AA; Hamam O; Raoof EA; Abeya S
J Egypt Soc Parasitol; 2010 Aug; 40(2):515-30. PubMed ID: 21246958
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin mRNA level as a parameter of disease progression in chronic hepatitis C and hepatocellular carcinoma.
Abd Elmonem E; Tharwa el-S; Farag MA; Fawzy A; El Shinnawy SF; Suliman S
J Egypt Natl Canc Inst; 2009 Dec; 21(4):333-42. PubMed ID: 21415870
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
16. BZW2, CDT1 and IVD Act As Biomarkers for Predicting Hepatocellular Carcinoma.
Jiang Z; Wei Z; Chen J; Yang F; Jiang Y; Lv L
Curr Cancer Drug Targets; 2023; 23(3):211-221. PubMed ID: 36056860
[TBL] [Abstract][Full Text] [Related]
17. Circulating AFP mRNA as a Possible Indicator of Hematogenous Spread of HCC Cells: A Possible Association with HBV Infection.
Montaser LM; Abbas OM; Saltah AM; Waked IA
J Egypt Natl Canc Inst; 2007 Mar; 19(1):48-60. PubMed ID: 18839035
[TBL] [Abstract][Full Text] [Related]
18. Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.
Kim GA; Han S; Kim HD; An J; Lim YS
J Viral Hepat; 2017 Nov; 24(11):990-997. PubMed ID: 28499070
[TBL] [Abstract][Full Text] [Related]
19. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
Mondal G; Saroha A; Bose PP; Chatterjee BP
Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.
Passos-Castilho AM; Lo Turco E; Ferraz ML; Matos C; Silva I; Parise E; Pilau E; Gozzo F; Granato C
J Gastrointestin Liver Dis; 2015 Mar; 24(1):43-9. PubMed ID: 25822433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
